विवरण
Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.
More Figures from This Paper
Figure 8
Correlation analysis between gut microbiota changes and hepatic inflammation markers in berberine-treated mice with autoimmune hepatitis.
chart
Figure 11
Supplementary experimental data (panel 11) from the berberine autoimmune hepatitis study, providing additional evidence of gut microbiota modulation and hepatoprotective effects in the concanavalin A mouse model.
chart
Figure 17
Graphical summary of berberine's mechanism of action in alleviating concanavalin A-induced autoimmune hepatitis in mice, highlighting its role in modulating the gut microbiota and restoring intestinal barrier integrity.
diagram
Figure 19
Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.
chart
Figure 20
Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.
chart
Figure 29
Gut microbiota sequencing or metabolomic data from the berberine-treated autoimmune hepatitis model, characterizing microbial community shifts and their potential functional implications.
chartFigure 18
ChartSource Paper
Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota.Cite This Figure
 > Source: Hao Yang et al. "Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modu." *Hepatology communications*, 2024. PMID: [38466881](https://pubmed.ncbi.nlm.nih.gov/38466881/)
<figure> <img src="https://pdfs.citedhealth.com/figures/38466881/458.png" alt="Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function." /> <figcaption>Figure 18. Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.<br> Source: Hao Yang et al. "Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modu." <em>Hepatology communications</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38466881/">38466881</a></figcaption> </figure>